证券代码：301166 证券简称：优宁维 上海优宁维生物科技股份有限公司 投资者关系活动记录表 6.请问当前核心在研项目的进展如何？ 答：投资者您好。公司目前主要围绕抗体和蛋白等领域持续开展 研发投入，截至 2024 年末，杭州抗体研发中心累计研发产品（配对抗 体、病理 IHC 抗体、伴随诊断抗体等原料抗体）SPU 数超 2,900 个， 南京蛋白研发中心累计研发产品（药物靶点、细胞因子等）SPU 数超 1,700 个，新增 one step Elisa 试剂盒等抗体衍生产品。谢谢 编号：2025-004 | | 特定对象调研 分析师会议 | | --- | --- | | 投资者关系活动类 | 媒体采访  业绩说明会 | | 别 | 新闻发布会 路演活动 | | | 现场参观 | | | 其他 (电话会议) | | 参与单位名称及人 | 通过"价值在线"参加公司 2024 年度网上业绩说明会的投资者 | | 员姓名 | | | 时间 2025 | 年 月 日 4 29 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | ...

Core Points - Amazon Web Services announced the establishment of the Greater Bay Area Industry Digital Empowerment Center in collaboration with the Nanshan District government, marking its sixth center in China and the only one in the Greater Bay Area, aimed at providing high-quality technology and solutions for local enterprises [1] - The Go Global center is designed to serve both domestic companies looking to expand internationally and foreign enterprises seeking to enter the Chinese market, facilitating a comprehensive international service platform [1][3] Group 1: Go Global Center - The Go Global center aims to lower the "psychological threshold" for companies venturing into unfamiliar global markets by offering customized solutions based on real needs [3] - The center has formed a service team that proactively addresses the challenges faced by companies in their international expansion efforts [3] - The center provides extensive support to companies like Di Shang Tie, which operates over 170,000 electric logistics vehicles across more than 200 cities in China, helping them navigate potential risks in international partnerships [4][6] Group 2: Case Studies of Companies - Di Shang Tie has expressed that the center's expert team has significantly boosted their confidence in international expansion by providing comprehensive reports on potential overseas partners [4] - Companies like Rayman Optoelectronics and Ruivode have successfully expanded globally, with Rayman participating in high-profile events like the 2022 Beijing Winter Olympics and Ruivode engaging in over 300 international exhibitions in 2024 [5][10] - The center has provided tailored support to Ruivode in overcoming challenges in entering the Dutch market, including assistance with talent recruitment and establishing distribution channels [10] Group 3: Service Offerings - The Go Global center operates on a model that integrates government guidance, enterprise collaboration, and platform services, creating a market-oriented international service "joint fleet" [11] - The center has partnered with renowned service providers like Dun & Bradstreet for consulting services, offering access to a vast database of global enterprises [13] - The center aims to enhance the international business environment in Nanshan District, promoting two-way interaction between domestic and foreign enterprises to drive high-quality economic development [14]

证监会审核华创证券投资咨询业务资格批文号：证监许可（2009）1210 号 未经许可，禁止转载 资料来源: Wind, 华创证券 ω · 本周，中信医药指数上涨1.04%，跑赢沪深300指数1.03个百分点，在中信30个一级行业中排名第1位。 · 本周涨幅前十名股票为怡和嘉业、润都股份、德源药业、智翔金泰-U、河化股份、荣昌生物、康弘药业、博腾股份、迈威生物-U、三元基因, • 本周跌幅前十名股票为ST香雪、创新医疗、爱朋医疗、*ST龙津、东方生物、恩威医药、*ST吉药、康惠制药、普瑞服科、翔宇医疗。 管 == $( +) 行情回顾 01 02 板块观点和投资组合 03 行业和个股事件 本周行情回顾 =半创研究 本周中信一级行业指数涨跌幅 本周涨幅排名前/后十名的股票 -40.829 ST香雪 怡和露业 40 200 22.7496 创新医疗 润都股份 | 21.83% 爱朋医疗 德源药业 19.07% 0% *ST龙津 智翔金泰-U 18.34% -1% 河化股份 东方生物 16.23% -29 圆威医药 美昌生物 15.38% -36 *ST吉药 康弘药业 15.3596 -11.54% -49 康惠制药 ...

第 = $( +) 行情回顾 01 02 板块观点和投资组合 03 行业和个股事件 本周行情回顾 本周中信一级行业指数涨跌幅 本周涨幅排名前/后十名的股票 倍益康 廣農制药 -24.51% 8.12% 无锡品海 *ST景ច -24.419 20.70% 1% 荣昌生物 中科学费 16.72% 0% 受用医疗 15.90% 三次降行 -1% 咖降药业 维康药业 15.10% -2% 科兴制药 海月药业 14.21% -3% 恩威医药 13.799 博迅生物 -4% 华森制药 11.55% 鹿得医疗 -5% 普瑞眼科 润都股份 11.26% -6 欧康医药 兴并眼药 10.46% -14.24% 15% 20% 25% 30% 35% -30% -25% -20% -15% -10% -5% 0% રેક્ટ 10% 证监会审核华创证券投资咨询业务资格批文号：证监许可（2009）1210 号 未经许可，禁止转载 资料来源: Wind, 华创证券 1 华创研究 ω · 本周，中信医药指数上涨1.08%，跑输沪深300指数0.03个百分点，在中信30个一级行业中排名第18位。 · 本周涨幅前十名股票为康惠制药、*ST ...

证券研究报告 医药生物行业生命科学服务系列报告（一） ——海外公司 Bio-Techne & Thermo Fisher 西部证券研发中心 2025年3月14日 分析师 | 李梦园 S0800523010001 邮箱地址 limengyuan@research.xbmail.com.cn 分析师 | 谭雨露 S0800524100004 邮箱地址 tanyulu@research.xbmail.com.cn 核心结论 CONTENTS 目 录 CONTENTS 目 录 02 Thermo Fisher 公司概述 01 Bio-Techne 公司概述 生命科学服务国内相关标的 03 Bio-Techne 公司介绍 3.1 3.6 4.5 5.0 5.6 6.4 7.1 7.4 9.3 11.1 11.4 11.6 5.9 15.2% 26.4% 10.3% 12.8% 14.2% 11.0% 3.5% 26.0% 18.7% 2.8% 2.0% 6.7% 0% 5% 10% 15% 20% 25% 30% 0 2 4 6 8 10 12 14 2013 2015 2017 2019 2021 2023 2025 ...